Cardiovascular Toxicities of Androgen Deprivation Therapy

Prostate cancer is the second leading cause of cancer death in men, and cardiovascular disease is the number one cause of death in patients with prostate cancer. Androgen deprivation therapy, the cornerstone of prostate cancer treatment, has been associated with adverse cardiovascular events. Emergi...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Curr Treat Options Oncol
Main Authors: Challa, Azariyas A., Calaway, Adam Christopher, Cullen, Jennifer, Garcia, Jorge, Desai, Nihar, Weintraub, Neal L., Deswal, Anita, Kutty, Shelby, Vallakati, Ajay, Addison, Daniel, Baliga, Ragavendra, Campbell, Courtney M., Guha, Avirup
Formato: Artigo
Idioma:Inglês
Publicado: Springer US 2021
Assuntos:
Cardio-oncology (MG Fradley, Section Editor)
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8053026/
https://ncbi.nlm.nih.gov/pubmed/33866442
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-021-00846-z
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares